Companies Dominating the Vitamin K Landscape
- Kappa Bioscience
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ADM
- Glanbia Plc
- Farbest Brands
- Adisseo
- Lonza Group
- Smidge Small Batch Supplements
- SternVitamin GmbH & Co. K.G.
- DSM
- Livealth Biopharma
- Pfizer Inc
- Solgar Inc
- NOW Foods
- Rabar Pty Ltd
- Nexeo Solutions
The vitamin K market is witnessing a surge in demand attributed to the growing awareness about its role in bone and cardiovascular health. The vitamin K market is dominated by key market players who are gaining traction in the market by focusing on product innovations and strategic partnerships to capitalize on this trend and expand their market presence.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of vitamin K is evaluated at USD 1.09 billion.
The vitamin K market size was valued at USD 1.01 billion in 2024 and is set to exceed USD 3.02 billion by 2037, registering over 8.8% CAGR during the forecast period i.e., between 2025-2037. Factors such as rapidly increasing cases of postmenopausal osteoporosis, cardiovascular disease, and an increase in the global geriatric population facing vitamin deficiencies will fuel the market growth.
North America industry is predicted to account for largest revenue share of 42% by 2037, influenced by increasing elderly population, rising awareness of the significance of nutritional benefits, enhanced investments in the research and development activities of Vitamin K supplements, and the presence of prominent vitamin K product manufacturers in the region.
The major players in the market are Glanbia Plc,Farbest Brands, Adisseo, Lonza Group, Smidge Small Batch Supplements, SternVitamin GmbH & Co. K.G., DSM, Livealth Biopharma, Pfizer Inc., Solgar Inc., NOW Foods, Rabar Pty Ltd, and others.
